← Back to Screener
abrdn World Healthcare Fund (THW)
Price$12.67
Favorite Metrics
Price vs S&P 500 (26W)-4.99%
Price vs S&P 500 (4W)-2.00%
Market Capitalization$506.33M
P/E Ratio (Annual)9.21x
All Metrics
P/CF (Annual)14.89x
Book Value / Share (Quarterly)$12.82
Indicated Dividend (Annual)$1.40
Revenue Growth (3Y)1.77%
Cash Flow / Share (Quarterly)$0.23
Payout Ratio (TTM)30.00%
Price vs S&P 500 (YTD)-2.64%
Gross Margin (TTM)-6.31%
Net Profit Margin (TTM)294.53%
EPS (TTM)$1.35
10-Day Avg Trading Volume0.08M
EPS Excl Extra (TTM)$1.35
Revenue Growth (5Y)-1.33%
EPS (Annual)$1.38
Dividend / Share (Annual)$1.33
ROI (Annual)8.69%
Gross Margin (Annual)-6.28%
Net Profit Margin (5Y Avg)186.63%
Cash / Share (Quarterly)$0.00
P/E Basic Excl Extra (TTM)9.04x
Revenue Growth QoQ (YoY)4.98%
EPS Growth (5Y)-7.39%
P/E Normalized (Annual)9.21x
ROA (Last FY)8.63%
Revenue Growth TTM (YoY)5.47%
EBITD / Share (TTM)$1.38
ROE (5Y Avg)7.86%
Operating Margin (TTM)-12.68%
Cash Flow / Share (Annual)$0.85
P/B Ratio0.99x
P/B Ratio (Quarterly)0.99x
EV / Revenue (TTM)49.04x
Net Interest Coverage (TTM)0.03x
ROA (TTM)9.27%
EPS Growth QoQ (YoY)137.80%
EV / EBITDA (TTM)11.18x
EPS Incl Extra (Annual)$1.38
Current Ratio (Annual)0.75x
Quick Ratio (Quarterly)0.67x
3-Month Avg Trading Volume0.15M
52-Week Price Return20.91%
EV / Free Cash Flow (Annual)18.42x
P/E Incl Extra (TTM)9.04x
P/S Ratio (Annual)39.63x
Asset Turnover (Annual)0.02x
52-Week High$13.19
Operating Margin (5Y Avg)13.18%
EPS Excl Extra (Annual)$1.38
26-Week Price Return-1.01%
Quick Ratio (Annual)0.67x
13-Week Price Return-0.39%
Total Debt / Equity (Annual)0.23x
Current Ratio (Quarterly)0.75x
Enterprise Value$626.329
Revenue / Share Growth (5Y)-5.69%
Asset Turnover (TTM)0.02x
Book Value / Share Growth (5Y)-1.91%
Pretax Margin (Annual)294.44%
Cash / Share (Annual)$0.00
3-Month Return Std Dev20.35%
Gross Margin (5Y Avg)19.44%
EBITDA CAGR (5Y)79.89%
EBITDA Interim CAGR (5Y)129.29%
ROE (Last FY)10.72%
Net Interest Coverage (Annual)-0.25x
EPS Basic Excl Extra (Annual)$1.38
P/FCF (TTM)22.01x
Receivables Turnover (TTM)34.60x
EV / Free Cash Flow (TTM)69.59x
Total Debt / Equity (Quarterly)0.23x
EPS Incl Extra (TTM)$1.35
Receivables Turnover (Annual)34.60x
ROI (TTM)9.34%
Dividend Growth Rate (5Y)-0.57%
P/S Ratio (TTM)39.64x
Pretax Margin (5Y Avg)186.63%
Revenue / Share (Annual)$0.34
Free OCF CAGR (5Y)-2.29%
Price vs S&P 500 (52W)-8.92%
P/E Ratio (TTM)9.04x
EPS Growth TTM (YoY)-44.49%
Year-to-Date Return0.00%
5-Day Price Return4.93%
EPS Normalized (Annual)$1.38
ROA (5Y Avg)6.30%
Net Profit Margin (Annual)294.44%
Month-to-Date Return9.51%
EBITD / Share (Annual)$1.38
Operating Margin (Annual)-12.65%
LT Debt / Equity (Annual)0.27x
P/CF (TTM)56.26x
ROI (5Y Avg)6.40%
P/E Excl Extra (TTM)9.04x
LT Debt / Equity (Quarterly)0.27x
EPS Basic Excl Extra (TTM)$1.35
Payout Ratio (Annual)94.55%
P/B Ratio (Annual)0.99x
Dividend / Share (TTM)$0.74
Pretax Margin (TTM)294.53%
Book Value / Share (Annual)$12.82
Price vs S&P 500 (13W)-1.08%
Net Margin Growth (5Y)4.48%
Dividend Yield (TTM)5.73%
Beta0.85x
P/FCF (Annual)14.89x
Revenue / Share (TTM)$0.34
ROE (TTM)11.68%
52-Week Low$10.10
About
A diversified closed-end fund investing in equity and debt securities across U.S. and international healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, medical devices, diagnostics, and healthcare REITs. Seeks current income and long-term capital appreciation from companies positioned for above-average growth.